Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cresyl violet is an organic compound traditionally used as a histological stain and recently investigated as a diagnostic contrast agent. In laboratory settings, it is the primary component of Nissl staining, which selectively labels the rough endoplasmic reticulum (Nissl substance) and nuclei in neurons by binding to acidic cellular components like RNA and DNA. This allows researchers to visualize cytoarchitecture and assess neuronal loss in conditions such as Alzheimer's disease, Parkinson's disease, and spinal cord injury. Clinically, cresyl violet is being explored as a topical dye for probe-based confocal laser endomicroscopy (pCLE). In this application, it provides real-time, in vivo microscopic imaging of the gastrointestinal mucosa, aiding in the diagnosis of gastric intestinal metaplasia and colorectal polyps by highlighting tissue architecture and cellular nuclei without the need for systemic injection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cresyl violet.